Cliniques Universitaires Saint-Luc — Clinical Trial Site

632 Registered trials

266 Currently recruiting

Organisation

Cliniques Universitaires Saint-Luc

Location

Sint-Lambrechts-Woluwe, Belgium

Identifier

ORG-100008950

Address

Hippokrateslaan 10, Batiment 54, 1200, Belgium

Departments

-
/
#0804: Department Paediatric Neurology
#1001: Hematology – Day Hospital
#1004: oncology
#1100: Medical Oncology
#11001:Pediatric Neurology
#170: Pneumologie
#3001: Centre de malformations vasculaires congenitales
#3102: Intensive Care
#40121: Dermatology
#40756: Rhumatology
#7054: Dermatology
#9145: Dermatology
03202
0501: Oncologie Médicale
0504 Medical oncology/Institut Roi Albert II
056002: Medical oncology
1050: Urology
1102: Oncology
1201: Pediatric oncology – hematology
1301: Internal Medicine
2050: Urology
2202: Hematology
2901 : Paediatrics - Paediatric Hepatology
301: Gastro-entérologie
40756: Neurologie pédiatrique
Acute Medicine
Cancer et Hématologie adulte et pédiatrique
Cardiology
Cardiovascular Department
Center for Reproductive Medicine
Centre de procréation médicalement assistée
Chirurgie gynécologique
Clinical research
Clinique du sein / Oncology – Breast Clinic
Clinique Universitaires Saint-Luc
Cliniques Universitaires Saint-Luc
Cliniques Universitaires Saint-Luc - Nefrology
Cliniques Universitaires Saint-Luc UCL Saint Luc
Congenital Vascular Malformations Department
Deparment of Medical Oncology
Department Hématologie et oncologie pédiatrique
Department of Dermatology
Department of Digestive Oncology
Department of Medical Oncology
Department of Nephrology
Department of Oncology
Department of Oncology, route 42
Department of Otolaryngology
Department of Pediatric Hemato-Oncology
Department of Pediatrics
Department of Pediatry
Department of Rheumatology
Dept of Medical Oncology/Institut Roi Albert II
Dept. of Medical Oncology
Dermatologie
Dermatology
Dermatology Department
Digestive Oncologie
Digestive Oncology
Division of Cardiology
Emergency Department
Endocrinology
Gastro Enterology
Gastro-entérologie
Gastro-Enterology
Gastroenterologist
Gastroenterology
Gastroenterology – Digestive Oncology
Gastroenterology (Pediatric)
General Internal and Infectious Diseases
General Internal Medicine and Infectious Diseases
General Medical Oncology
Gynaecology
Gynaecology-Andrology
Gyneacology and Andrology
Gynécologie
Haematology
Head of clinic of orthopeadic and traumatology
Head of theHaemostatis and Thrombosis Unit
Hématologie
Hématologie et Oncologie Pédiatrique
Hematologie Pediatrique
Hematologie voor volwassenen
Hematology
Hematology Department
Hematology oncology pediatric
Hematology, Haemostasis and Thrombosis Unit
Hematology/oncology
Hémotologie et oncologie pédiatrique
Hepato gastroenterology pediatric
Hepato-biliar-pancreas
Hepato-Gasteroenterology
Hépato-gastro-entérologie
Hepato-gastro-enterology
Hépato-gastroentérologie
Hepato-Gastroenterology
Hepatogastroenerology
Hepatogastroenterology
Hepatology
Hepatology -Gastroenterology
Infectiology
Infectiology Médecine interne
Infectious Disease and Internal Medicine
Infectious Diseases
Institut Roi Albert II Cancer Center - Phase 1 Unit
Intensive Care
Intensive Care Unit
Internal medicine
Internal Medicine and Infectious Disease
Internal medicine and Infectious diseases
Interstitial lung diseases
Médecine physique et réadaptation
Medical Oncology
Medical oncology (Institut Roi Albert II)
Medical Oncology Department
medical oncology/ Institut Roi Albert II
Medical Oncology/Institut Roi Albert II
Medical onocology
Melanoma department
N/A
NA
Neonatology
Néphrologie Pédiatrique
Nephrology
Nephrology department
Nephropediatrics
Neurologie
Neurology
Neurology department
Nuclear Medicine
Oncologie
Oncologie Médicale
Oncologie médicale (Medical Oncology)
Oncologie médicale/ Medical Oncology
Oncology
Oncology and Gasto-Enterology Department
Oncology Department
Oncoogy
Ophthalmology
ORL
Orthopedics
Orthopedics and Musculoskeletal Traumatology
Otorhinolaringologie
Otorhinolaryngology Department
Paediatric Department
Paediatric haemato oncology
Paediatric haemato-oncology
Paediatric Haematology and oncology
Paediatric hemato-oncology
Paediatrics
Paediatry
Pediatric Cardiology
Pediatric Department
Pediatric Endocrinology
Pediatric gastroenterology
Pediatric Gastroenterology and Hepatology
Pediatric hemato-oncology
Pediatric hemato-oncology department
Pediatric hematology and oncology
Pediatric Neurology
Pediatric Oncology and Hematology
Pediatrics
Pneumolgy
Pneumology
Pneumology Department
Pneumology, level -2
Psychiatry
Pulmonary Medicine
Pulmonology
Radiotherapist
Radiotherapy
Radiotherapy-oncology
Respiratory oncology
Rheumatology
Route 608, level -2
Service d'oncologie médicale
Service d'Orthodontie et de Parodontologie
Service de chirurgie et transplantation abdominale
Service de Dermatologie
Service de Dermatology
Service de gastro-entérologie pédiatrique
Service de neurologie
Service de pneumologie
Service oncologie médicale
UC Louvain Brussels / Department of Pediatrics
UCL Saint Luc (#1)
Unité d'Oncologie Médicale
Urology
Urology & Physiology
Urology department
Urology-Oncology

Clinical trials at this site (632)

Search interface

Phase 3 study of perioperative dostarlimab in participants with untreated T4N0 or stage III dMMR/MSI-H resectable colon cancer Ended

2023-503265-27-00 Participants with Untreated T4N0 or Stage III dMMR/MSI- 5 2023-11-23
A phase I/II open label, multicenter study evaluating the feasibility, safety and efficacy of point-of-care manufactured antiBCMA CAR T cell… Ended

2022-500782-27-00 relapsed/refractory Multiple Myeloma 7 2023-11-14
A Phase 3b/4 Randomized, Double-Blind, Double-Dummy, Active Comparator-Controlled Study, Comparing the Efficacy and Safety of Upadacitinib V… Ended

2022-502578-18-00 Rheumatoid Arthritis 11 2023-11-07
A Study to Evaluate Atezolizumab and Bevacizumab, with and without Tiragolumab, In Patients With Untreated Locally Advanced or Metastatic He… Ended

2023-503422-39-00 Hepatocellular Carcinoma (HCC) 5 2023-10-20
A Phase 1/2 Study of BMS-986449 with and without Nivolumab in Participants with Solid Tumors Ended

2023-503484-42-00 Advanced, metastatic, solid malignancy 7 2023-10-19
A study to test whether spesolimab helps people with Generalized Pustular Psoriasis (GPP) who need treatment for repeated flares Ended

2022-502128-38-00 Generalized Pustular Psoriasis 11 2023-10-11
Safety and efficacy analysis of an antibody associated with a chemotherapy for patients with a triple negative metastatic breast cancer. Ended

2022-502369-10-00 Triple negative metastatic breast cancer 5 2023-10-02
Phase I/II study of QEL-001 in A2-mismatch liver transplant patients Ended

2024-516193-30-01 Prevention of liver transplant rejection 7 2023-10-02
A Study to Learn About the Safety of BIIB080 and Whether it Can Improve Symptoms of Participants With Mild Cognitive Impairment Due to Alzhe… Ended

2022-501644-15-01 Mild Cognitive Impairment due to Alzheimer's Disease Al 4 2023-09-28
A Study to Compare the Efficacy and Safety of Idecabtagene Vicleucel with Lenalidomide Maintenance Therapy Versus Lenalidomide Maintenance T… Ended

2022-501346-30-00 Newly Diagnosed Multiple Myeloma with Suboptimal Respon 5 2023-09-25
A Study Evaluating the Efficacy and Safety of Inavolisib Plus Fulvestrant Versus Alpelisib Plus Fulvestrant in Patients with Hormone Recepto… Ended

2022-502322-41-00 Metastatic breast cancer 5 2023-09-12
A study to test different doses of obrixtamig (BI 764532) combined with ezabenlimab in patients with Small Cell Lung Carcinoma and other neu… Ended

2022-502728-30-00 Small Cell Lung Carcinoma expressing DLL3 3 2023-08-25
A Phase 3 Placebo-controlled Study of Milvexian after an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack Ended

2022-501176-26-00 Acute Ischemic Stroke and High-Risk Transient Ischemic 5 2023-08-04
A Study to Evaluate the Effect of Resmetirom on Clinical Outcomes in Patients With Well-compensated NASH Cirrhosis Ended

2024-510627-20-00 Non-alcoholic Steatohepatitis (NASH) Cirrhosis 5 2023-07-28
A study to evaluate the safety, tolerability and the effects of Ixodes ricinus-Contact Phase Inhibitor (Ir-CPI) in adult patients with spont… Ended

2022-500491-53-00 Spontaneous intracerebral haemorrhage 4 2023-07-27
HOVON 164 HL: Tislelizumab plus Gemcitabine and Cisplatin for Relapsed or Refractory Hodgkin Lymphoma followed by Tislelizumab Consolidation… Ended

2022-502225-17-00 Hodgkin lymphoma 4 2023-07-14
A trial to see if the combination of fianlimab with cemiplimab works better than pembrolizumab for preventing or delaying melanoma from com… Ended

2022-501576-25-00 Melanoma 5 2023-07-07
A Study to Examine the Efficacy and Safety of ZX008 in Subjects with CDKL5 Deficiency Disorder Ended

2023-506269-78-00 CDKL5 Deficiency disorder 5 2023-06-20
A Study of EOS301984 in Adult Participants with Advanced Solid Tumors Ended

2023-503844-14-00 Advanced Solid Tumors 1 2023-06-13
A study to test trimodulin in adult hospitalized patients with severe pneumonia Ended

2022-501352-28-00 Severe community-acquired pneumonia (sCAP) 5 2023-06-07
Phase 3 Clinical Trial of Gedatolisib in Patients with HR Positive, HER2 Negative Advanced or Metastatic Breast Cancer (VIKTORIA-1) Ended

2022-502145-10-00 Hormone Receptor (HR)-Positive, Human Epidermal Growth 5 2023-06-06
A study in metastatic breast cancer patients receiving eftilagimod alpha or placebo in combination with a standard chemotherapy (paclitaxel) Ended

2024-511023-34-00 HER2-neg/low metastatic breast cancer 10 2023-05-05
A research study looking at long-term treatment with Mim8 in people with haemophilia A (FRONTIER 4) Ended

2022-502215-10-00 Haemophilia A (with or without inhibitors) 5 2023-05-04
An early access study of ivosidenib in patients with a pretreated locally advanced or metastatic cholangiocarcinoma Ended

2022-501463-40-01 Locally Advanced or Metastatic Cholangiocarcinoma 5 2023-05-03